MSLE

Satellos Bioscience Inc. MSLE

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

No SEC XBRL data

This company has no XBRL financial filings on file with SEC EDGAR. Common for ADRs, recent IPOs, OTC-listed names, and foreign filers that haven't filed 20-F yet.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$59.58M total
Reading the latest SEC filing…

Financial metrics will appear once SEC EDGAR data is ingested for this company.

Loading ratio trend…

About Satellos Bioscience Inc. (MSLE): stock profile, AI score and financials

Satellos Bioscience Inc. (MSLE) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. MSLE is not currently included in 13F Pro's AI-ranked quality universe — this company has no xbrl financial filings on file with sec edgar. common for adrs, recent ipos, otc-listed names, and foreign filers that haven't filed 20-f yet. Top institutional holders of MSLE by reported 13-F value include FRANKLIN RESOURCES, Siren, L.L.C., Vivo Capital, based on the most recent SEC filings. MSLE trades on the Nasdaq exchange and files with the SEC under CIK 1421642. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MSLE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Satellos Bioscience Inc. directly from SEC EDGAR.

SEC EDGAR: CIK 1421642 →